Introduction
============

At the heart of elucidating the complexity of cellular cooperation in metazoans is determining the protein--protein interactions (PPI) that enable cell--cell communication and the dynamic functioning of cellular pathways that respond to internal and environmental signals. Evolution of multicellularity would necessitate the formation of new interactions between new genes while accommodating and adapting proteins from the precursor unicellular network. New systems of cellular communication and cell division control must have evolved early on in the evolution of multicellularity. Breakdown of such systems can lead to disease, particularly cancer, because cancer arises from the loss of a cell's normal compliance with the ground rules of multicellular phenotypic organization. Most recently, cancer-related "gatekeeper" genes, which are involved in cellular signaling and growth processes, were phylogenetically mapped to the emergence of multicellularity in metazoa ([@mss218-B5]), and the rise of cancer together with multicellularity was further highlighted in the context of sequencing the *Amphimedon queenslandica* (sponge) genome ([@mss218-B48]).

Networks of PPI have evolved under natural selection over millions of years, leaving their mark in the molecular sequences of proteins, which we can now study thanks to the abundance of sequence data provided by advances in sequencing technology. Interactions between proteins can be predicted through their correlated evolutionary rates ([@mss218-B34]; [@mss218-B20]). Detecting molecular coevolution can thus help to elucidate functional interactions between molecules within and between cells to gain insight into biological processes, pathways, and the networks of interactions important for cellular function.

Our recently developed method MatrixMatchMaker (MMM) implements an efficient computational strategy to detect sequence coevolution ([@mss218-B51]; [@mss218-B38]). It was shown to be more accurate than previous coevolutionary methods, more accurate than coabundance predictions, and most accurate in predicting protein complexes ([@mss218-B4]). Using this tool on recently available data, we are now able to resolve two subnetworks of human protein coevolution: one involving ancestral eukaryotic proteins and the other proteins specific to animals or having been recruited in animals to play roles in multicellular communication and control. That latter subnetwork exposes associations among genes required for multicellularity, providing opportunities to study interactions among systems contributing to organismal homeostasis. More specifically, we here describe a human protein coevolution network that contains many proteins previously uncharacterized in terms of protein interactions and expression patterns. We, however, find strong evidence for genetic interaction among these proteins when considering human disease data, particularly links among genes involved in ciliopathies and cancer. The nonmotile primary cilia play important roles in chemo-, mechano-, and thermosensation in vertebrates and coordinate signaling with motility or with cell division and differentiation ([@mss218-B42]). Proteins associated with centrioles, centrosomes, and cilia have been implicated in both ciliopathies and cancer in human ([@mss218-B3]).

Materials and Methods
=====================

Input Data for MMM
------------------

For the construction of the human coevolution network, we used the version of the OMA Browser ([@mss218-B2]) dated November 2010, to obtain the 20,804 OMA groups containing a human protein. Only eukaryotic orthologs (from 103 genomes) were considered in these groups, having at least two sequences. We also considered an alternative clustering scheme to that used in OMA. For this, all eukaryotic proteins reciprocally best matching with human proteins (1:1 orthologs) were added to the human sequence to form a group, though we did not require all pairwise 1:1 orthologs to hold over all species. This alternative clustering yielded 20,225 groups.

MAFFT ([@mss218-B21]) was used to create multiple sequence alignments for each group; evolutionary distance matrices were obtained by using protdist (from PHYLIP 3.69 \[[@mss218-B7]\], modified to allow selenocysteine and pyrolysine amino acids and for identical sequences to have a distance of 0.0 \[protdist sets these to 0.00001\]).

MMM searches for pairs of evolutionary distance submatrices that are similar within a specified tolerance. Such matching submatrices represent similar phylogenetic subtrees, indicating coevolution over the evolutionary history of the subset of taxa included in the submatrices. The number of taxa found in the matching submatrices is the MMM score; higher scores provide stronger evidence for covariation of the two protein families. MMM is scale independent and thus allows for the detection of correlated distances, not just identical distances, so that protein coevolution may be detected despite the proteins evolving at different rates. We used MMMvII ([@mss218-B38]), an efficient and exact algorithm for identifying the submatrices. All-by-all pairwise combinations (216,850,725 for the OMA groups and another 204,535,425 for the 1:1 groups) were analyzed, only allowing proteins belonging to the same species to be included in possible MMM solutions (parameter: *u*, so that only distances between the species in common in the two alignments were considered) and with a match tolerance (parameter: *a*) set to 0.1 (10%), which has been previously shown ([@mss218-B51]; [@mss218-B4]) to provide adequate sensitivity and specificity.

An average matrix was obtained by averaging the matrix entries of each protein family for each pairwise species comparison, over all of the OMA groups' matrices. The MMM score for each matrix to the average matrix was used to calculate the so-called G score and the sum of MMM plus G scores (MMMpG), which is used to correct MMM scores between groups for the part of their coevolution that is due to the species phylogeny (see [@mss218-B4] for details).

Evolutionary Age of Orthologous Groups
--------------------------------------

We also used the average matrix described earlier to compute the relative rate of an OMA group's evolution, as the ratio of its rate (average distance to the human ortholog) over the average matrix's rate (same subset of species). Neighbor Joining ([@mss218-B7]) and Minimum Evolution (ME) trees ([@mss218-B41]) were obtained from the average matrix, showing generally good agreement with the eukaryotic species phylogeny but with some artifacts arising due to long-branch effects. We chose to use the ME tree ([supplementary fig. S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). For each OMA group, its species distribution was used to determine the position in the ME tree for the last common ancestor of all the sequences in the group. The age of the protein is simply then the evolutionary distance from the human sequence to this internal node. We chose the edge between the branch node leading to the unicellular *Monosiga brevicollis* (at a distance of 0.48) and the node leading to early multicellular animals (at a distance of 0.45) as the delimiter for "new" groups because all species with a smaller distance to human are multicellular animals. The "old" OMA groups include human orthologous proteins from nonanimals and animals.

Map Equation Clusters
---------------------

Map equation ([@mss218-B39]) was used to cluster the network with MMM and MMMpG scores 12 and higher according to its topology. A total of 145 clusters were obtained for the OMA groups' network and 97 for the 1:1 network. The age of each cluster was taken as the average age of the nodes included in the cluster, and each cluster was then labeled either "NEW" or "OLD" according to their average distance being \<0.46 or \>0.46, respectively. Because there are some "old" nodes in the "NEW" clusters, and conversely, "new" nodes in the "OLD" clusters, we use capitalization to differentiate the age of clusters and genes.

Orthologous Groups
------------------

The division of the MMM network into two distinct groups of NEW and OLD clusters is partly an artifact of the methodology used in defining sets of orthologs, because it is more difficult to identify distant orthologs for rapidly evolving proteins (making old proteins appear newer). The ages of the proteins are only gross estimates, because missing sequences from unfinished genomes, Basic Local Alignment Search Tool (BLAST) parameters, and clustering approaches will all affect the composition of the orthologous clusters. We attempted to add potentially more distant human orthologs by creating protein families that considered only the 1:1 reciprocal best BLAST hits to the human proteins, which is not nearly as strict a criterion for orthology as that used by OMA, which does not permit paralogous proteins to be included in their groups ([@mss218-B2]). We think this more relaxed approach would be less likely to underestimate the age of proteins. This indeed resulted in larger matrices on average and older ages ([supplementary data set S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). The resulting 1:1 MMM network was quite similar to the one obtained from the OMA groups, however, and does not alter our conclusions. We therefore chose to present the network from the better established orthologous clusters assembled by OMA, which are most likely to represent single-protein functions and also to yield better quality alignments and distance matrices.

Mapping of OMA Proteins and MMM Networks to Known Interactions, Coexpression Data, Gene Ontology Functional Annotation, Pathways, and Diseases
----------------------------------------------------------------------------------------------------------------------------------------------

The OMA proteins and the MMM networks were annotated with many resources, and these annotations can be found in [supplementary data sets S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) (protein annotations) and [S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) (MMM network annotation), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online. The descriptions and the references for these are given in [supplementary text S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online ([supplementary methods](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) and results, [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online).

### Coexpression Data

Data from the E-MTAB-62 data set, a meta analysis of gene expression data from ∼5,400 human samples representing 369 different cell and tissue types, disease states, and cell lines, all on the same platform of the Affymetrix GeneChip Human Genome HG-U133A (G-U133A) obtained from GEO and ArrayExpress ([@mss218-B26]), were obtained from ArrayExpress (<http://www.ebi.ac.uk/arrayexpress/>, last accessed 2012 September 23). The processed data were mapped to the OMA human proteins, and all expression values for a gene were averaged. The Pearson correlation coefficient was then calculated for all pairwise comparisons of genes over all the samples. Correlation values of expression data were also obtained from COXPRESdb ([@mss218-B33]).

### Ciliopathies

"Cilia" and "ciliopathy" were both used as search terms in Gene Ontology (GO), Online Mendelian Inheritance in Man (OMIM), and National Center for Biotechnology Information (NCBI) Gene and by searching through reviews of ciliopathies in the literature ([@mss218-B9]; [@mss218-B52]); the ciliome database (<http://ciliome.com>, last accessed 2012 September 23) ([@mss218-B18]) that had at least three studies linking a gene to cilia; and from the <http://ciliaproteome.org> (last accessed 2012 September 23) database ([@mss218-B10]). We found 323 human genes involved in cilia or ciliopathies that we could map to the OMA groups.

### Cancer Genomes

Data from cancer genome sequencing were obtained from the International Cancer Genome Consortium Data Portal on 27 May 2011. Ensembl IDs for the mutations were mapped to the OMA group human proteins, and the number of samples in which the gene was (nonsilently) mutated was counted. Genes mutated in fewer than three samples were ignored. Ovarian cancer data were updated on 29 June 2011 from the [supplementary table](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) in [@mss218-B50]. The OMA protein annotation file ([supplementary data set S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online) shows the total number of samples over all cancer genomes.

Results
=======

The MMM Coevolution Network Splits According to Evolutionary Age
----------------------------------------------------------------

We have previously shown that MMM scores have predictive value for known PPI ([@mss218-B51]; [@mss218-B4]). Here, we obtained MMM scores in an all-by-all analysis of distance matrices from orthologous groups containing human proteins ([supplementary data set S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online), retaining scores of at least 12 in what we refer to below as the MMM12+ network ([supplementary data set S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). MMM-D, a database of scores from the MMM12+ network (containing 6,422 pairs from 1,608 protein families) and all known as well as orthologous protein interactions (323,702 interactions between 11,836 protein families), is available at <http://tillier.uhnres.utoronto.ca/MMMD.php> (last accessed 2012 September 23).

Clustering of the network, strictly based on topology using the Map equation ([@mss218-B39]), revealed two large subnetworks separated in their evolutionary age: one on average younger than the origin of animal multicellularity (MMM12+NEW) and one predating that origin (MMM12+OLD) (see Materials and Methods and [supplementary fig. S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). Connecting the two subnetworks are MMM12+NEW/OLD edges. For clarity, we display the smaller MMM13+ network in [figure 1](#mss218-F1){ref-type="fig"}*A*. F[ig]{.smallcaps}. 1.The MMM13+ network. (*A*) This display of the MMM13+ network was produced using Cytoscape v.8.0's spring-embedded layout ([@mss218-B46]). Clustering of the network according to its network topology was separately done using the Map equation algorithm (see Materials and Methods). The pink nodes indicate that they are found in evolutionarily OLD clusters, that is, Map equation clusters of the MMM12+ network with an average distance dating to before the origin of animals. The blue nodes are in clusters that have an average age no older than the origin of animals, although some individual nodes within those clusters are older. (*B*) The MMM12+ network, represented as a heat map ([@mss218-B49]), also shows fewer old-to-new edges than new-to-new or old-to-old edges. (*C*) The degree for nodes in the known interaction network is higher for older nodes, indicating that more interactions are known among the older proteins.

The random expectations for old--old, new--old, and new--new frequencies in the network are simply derived from the binomial expansion. A χ^2^ test ([supplementary table S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online) revealed a highly significant overrepresentation of new--new and old--old node connections within the MMM12+ network, whether using OMA groups (*P* \< 1.1E -- 311) (as is shown in [fig. 1](#mss218-F1){ref-type="fig"}*B*) or MAP clusters (*P* \< 1.1E -- 311). This remained true when we analyzed the network of all known protein interactions (*P* \< 1.1E -- 311), such that on average, old proteins interact with old proteins and new with new. [Figure 1](#mss218-F1){ref-type="fig"}*C* shows that proteins in the known interaction network also have more connections when they are old.

Agreement with Known Interactions
---------------------------------

Overall, higher MMM scores have predictive value for known PPI. [Figure 2](#mss218-F2){ref-type="fig"}*A* shows that higher scores give greater precision (the frequency of predictions that were previously known interactions), which is approximately 10% at MMM ≥ 12 and climbs to over 30% at MMM ≥ 16. These values are comparable to biochemical high-throughput methods applied to identify protein interactions in human, such as yeast-2-hybrid and immunoprecipitation/mass spectrometry, whose predicted interactomes overlap with literature-curated PPI networks between 2--8% and 6--11%, respectively, and that have mutual overlap of 7.9% ([@mss218-B40]; [@mss218-B6]). We thus set a threshold of 12 for our network, which we call MMM12+. As seen in [figure 2](#mss218-F2){ref-type="fig"}*A*, the highest coevolution scores are not found in the Human Protein Reference Database (HPRD) database, the gold standard for human PPI, but are validated by other data sets, particularly the Comprehensive Resource of Mammalian Protein Complexes (CORUM) (see [supplementary methods](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online, for a list of databases used for known interactions). We also considered the scores from the *Drosophila* interactome ([@mss218-B13]) and found that these rapidly increased with higher MMM scores (giving 36.3% precision for PPI prediction with MMM12+), also indicating agreement with this orthologous network ([fig. 2](#mss218-F2){ref-type="fig"}*B*). F[ig]{.smallcaps}. 2.Accuracy of MMM. (*A*) Precision of MMM predictions (the frequency of coevolving pairs that are known interactions from PPI databases) increases with higher MMM score thresholds (*x* axis). Considering HPRD only, it contains far fewer interactions, and none with very high MMM scores. (*B*) MMM scores correlate with the average interaction scores from *Drosophila* based on mass spectrometry analyses. (*C*), (*D*)*,* and (*E*) show a high correlation of MMM scores with average scores from other PPI prediction methods (IntnetDB, STRING, and HumanNet, respectively, each with their own scoring scale); this is true for all MMM predictions and for the subset that are known interactions. The correlation coefficient is shown for the MMM predictions, and error bars indicate one standard deviation over all MMM pairs. (*F*) Node degree frequency for proteins in the known interaction network and in the MMM12+ network shows that they are both scale free.

Our data also show agreement with data from other databases that include predicted interactions ([fig. 2](#mss218-F2){ref-type="fig"}*C*--*E*). Although STRING ([fig. 2](#mss218-F2){ref-type="fig"}*D*) uses phylogenetic profiles as part of its prediction score, which should be correlated with MMM scores, this approach is only used for their prediction of bacterial protein interactions. HumanNet ([@mss218-B24]) includes phylogenetic profiling as part of their prediction approach, and as expected, those scores are higher for gene pairs in the MMM12+ network ([fig. 2](#mss218-F2){ref-type="fig"}*E*).

The structure of the network also agrees well with known interactions: [figure 2](#mss218-F2){ref-type="fig"}*F* shows the degree distribution for the known interaction network of all 20,839 proteins in our data set along with the degree distribution, which is consistent with the power law and is typical for PPI networks.

Because interaction prediction data sets make use of the GO database, we also considered similarity of functional annotation using the Parent--Child algorithm ([@mss218-B1]; [@mss218-B12]), which considers the GO hierarchy and thus assigns lower *P* values to shared more-specific GO terms ([supplementary text S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). MMM proteins in interactions are more commonly found to share the same GO annotation compared with random pairs. For cellular component, MMM12+ pairs are found to have the same annotation more often than expected (*P* = 1.1E − 124, Pearson's χ^2^ with Yates' continuity correction) and with significantly lower *P* values (*P* = 8.26E − 16, Mann--Whitney *U* test). Similarly, for biological process, MMM12+ pairs share the same annotation more often than expected (*P* = 9.2E − 281*,* Pearson's χ^2^ with Yates' continuity correction), also with significantly lower *P* values (*P* = 1.49E − 63, Mann--Whitney *U* test). This shows that MMM predictions are enriched for functionally interacting pairs of proteins. In [supplementary figure S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online, we show a strong correlation between MMM scores and the *P* values indicating that higher MMM scores predict functionally related protein pairs.

The majority of known and interologous interactions were concentrated between the nodes within the ancient MMM12+OLD network ([fig. 1](#mss218-F1){ref-type="fig"}). MMM12+NEW thus revealed a subnetwork of coevolving genes that are more evolutionarily recent and that are not generally known to have interaction partners.

The NEW network contained many proteins whose interactions remain uncharacterized. For example, of the 263 nodes included in the MMM12+ network with no known interactions in any of the databases interrogated, 235 (89%) were new nodes (219 of these, or 83% of the 263, are in NEW clusters). [Figure 3](#mss218-F3){ref-type="fig"}*A* shows the frequency of NEW nodes in the MMM12+ network decreasing as their degree in the known interaction network increases, indicating that new nodes tend to have few known interactions. F[ig]{.smallcaps}. 3.New nodes and NEW network. (*A*) Frequency of NEW nodes decreases with increasing degree. (*B*) Frequency of node age for all proteins analyzed and for the known and MMM12+ networks. (*C*) The relative evolutionary rate (rates ratio to average matrix), as a function of the age of proteins is plotted for all proteins analyzed and for those in the MMM12+ network. The range was much reduced for proteins in the network, indicating that these neither evolve extremely quickly nor slowly. (*D*) The difference between the rates ratio of two proteins interacting (MMM12+ Known) or coevolving (MMM12+) decreases with MMM score, indicating that coevolving proteins also have similar rates of evolution.

We considered that this observation could be due to a bias in the known protein interaction network for proteins that are conserved from yeast to human, because the yeast interactome is better characterized, and we did use interologs in our assignment of interacting proteins. We thus compared the frequency distribution for the age of all proteins (20,839), of proteins in the known interaction network (11,581), and in our MMM12+ network (1,608), and did not see this bias ([fig. 3](#mss218-F3){ref-type="fig"}*B*). MMM12+ was less biased toward new nodes (59%); however, both networks were similarly extremely biased against interactions with very new proteins.

Proteins with identified human orthologs in the *Drosophila* proteomics network (1,359) of protein complexes are predominantly old (889), and the interactions (2,152) found between these genes are statistically significantly biased (*P* \< 6.6E − 117; [supplementary table S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online) toward old--old interactions (1,456) and against new--new interactions (143). Overall, we found that known interactions favor new proteins but that proteins interacting in complexes and coevolving proteins tend to be old proteins with higher degree ([fig. 1](#mss218-F1){ref-type="fig"}*C*).

Evolutionary Rates
------------------

Protein coevolution can only be recognized if the proteins in question have undergone a sufficient amount of evolutionary change. Therefore, for recently arisen proteins, the rate of their evolution must have been sufficiently high to detect their coevolution among a smaller set of species. We considered the relative rate of evolution of each OMA group to the average rate over all proteins. A ratio above 1 indicates a fast rate and a ratio below 1 a slow rate (see Materials and Methods). [Figure 3](#mss218-F3){ref-type="fig"}*C* shows the rate ratio for all OMA groups, and for the subset in the MMM12+ network, plotted against the evolutionary age of the protein family. Very high rate ratios were not found in our network. We believe this is because the majority of such rapidly evolving proteins would evolve too quickly for enough orthologs to be detectable by BLAST or have emerged too recently to produce OMA groups big enough to yield high MMM scores. Conversely, slowly evolving proteins need to be old enough to have accumulated enough substitutions.

When we considered the nodes only present in our network, the range of evolutionary rate ratios was much reduced. Additionally, when looking at the difference in the rate ratio between the pairs of connected proteins ([fig. 3](#mss218-F3){ref-type="fig"}*D*), we saw a decrease with MMM score, indicating that the most strongly coevolving proteins also tend to evolve at similar rates (not just correlated rates). This remained true in the MMM12+ subnetwork of known interactions ([fig. 3](#mss218-F3){ref-type="fig"}*D*), which had on average even more highly similar rates (although the variance is quite high). In [supplementary figure S3](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online, we show the frequency distribution of the difference in the rate ratio in the MMM12+ network and the known PPI network. In both of these networks, protein pairs evolve at more similar rates than do protein pairs drawn from a randomized network.

Coexpression Data
-----------------

To help elucidate the nature of the coevolution between the more recently evolved proteins and whether coevolution could possibly be entirely attributed to their coexpression ([@mss218-B14]), we considered expression data using the Pearson correlation of genes from COXPRESdb and from E-MTAB-62, a more recent compilation of expression values across a wide range of conditions and tissues in human ([@mss218-B26]).

We found that coexpression values (as measured by Pearson correlation) do correlate with the MMM score, and as expected, known PPIs had high correlation values ([fig. 4](#mss218-F4){ref-type="fig"}*A*). The E-MTAB-62 set showed these effects much more strongly than did the COXPRESdb data set, but only 66% of the edges in the MMM12+ network had both genes present in the E-MTAB-62 data set and only 8% of them could be mapped onto COXPRESdb data. There was no correlation between the two databases (Pearson *R*^2^= 0.001). F[ig]{.smallcaps}. 4.MMM coevolution and coexpression. (*A*) The average Pearson correlation (*R*^2^) measuring the coexpression of gene pairs in the MMM12+ and its subset of known interactions (MMM12+ Known) increases with MMM score. (*B*) Frequency distribution of the Pearson correlation (*R*) of coexpression over the E-MTAB-62 data of gene pairs in the All Known and MMM12+ networks. For the known interactions found in MMM12+ (blue solid line), the frequency distribution was found to be skewed toward higher correlations. The overall MMM12+ network distribution had fewer high correlation values (green solid line), particularly when only the subnetwork of NEW clusters was considered (red solid line). When considering all the known interactions, we found higher correlation values when both genes were old (orange dotted line) but significantly less than if the genes were also coevolving (i.e., in MMM12+; blue solid line). Newly interacting genes are less likely to be coexpressed. The distribution of known interactions when one of the genes was "new" (blue and purple dotted lines) was similar to the distribution from the MMM12+NEW network (red solid line).

Although we could obtain the correlation of expression data for over 80% of the edges for the known interactions, only 56% of the edges in the NEW network had coexpression information in at least one of the two databases we considered. This suggests that many of the MMM12+NEW genes in our network were not on the expression arrays and were otherwise poorly characterized (data not shown).

The frequency distribution of Pearson correlations in the E-MTAB-62 data set ([fig. 4](#mss218-F4){ref-type="fig"}*B*) was found to be skewed toward higher values when considering only the known interactions (blue solid line). The overall MMM12+ network distribution had fewer high correlation values (green solid line), particularly when only the subnetwork of NEW clusters was considered (red solid line). Of the MMM12+ known interactions, 76% had correlation values greater than 0.2 in either expression data set, whereas only 21% of the coevolving proteins in the NEW network reached that threshold.

Comparing these distributions in the network of all known interactions, we also found higher correlation values when both genes in the interaction were old (orange dotted line) but significantly less than if the genes were also coevolving (blue solid line). The distribution of known interactions when one of the genes was "new" (blue and purple dotted lines) was similar to the distribution in the MMM12+NEW network (red solid line).

Functional Annotation
---------------------

To better annotate the MMM12+NEW coevolution network, we made use of GO and several pathway databases (annotations are found in [supplementary data sets S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) and [S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). Statistically overrepresented GO terms are provided in [supplementary data set S3](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online. The MMM12+NEW network was found to be enriched for extracellular proteins, cell anchoring and adhesion proteins, the cytoskeleton, and cilia. We also saw a link between these proteins and cell division, control of the cell cycle, and multicellular development.

### Human Diseases

We used data from Online Mendelian Inheritance in Man (OMIM), Catalogue of Somatic Mutations in Cancer (COSMIC), and Gene Signature Database (GeneSigDB) to assess the relationship between protein age and disease ([table 1](#mss218-T1){ref-type="table"}). (Although also considered, the disease classifications in the Genetic Association Database did not yield any statistically significant results.) When considering all proteins mapped to OMA (not just in the MMM12+), we found that old genes were more likely to be implicated in OMIM diseases. This was especially true for proteins involved in enzyme or protein deficiencies and in ciliopathies. From COSMIC, however, we found that proteins involved in cancer were more likely to be new genes. The overrepresentation of genes involved in cancer among this set had been noticed previously ([@mss218-B5]). Table 1.Disease Functional Annotation.MembershipNew vs. Old[^a^](#mss218-TF1){ref-type="table-fn"}NEW vs. OLD[^b^](#mss218-TF2){ref-type="table-fn"}*N*Overrepresented*PN*Overrepresented*P*OMIM2,476old1.74E-07315------OMIM \"Deficiency\"322old5.55E-1455------Cilia/ciliopathy323old5.8E-1142NEW6.54E-03COSMIC mutation4,555new8.43E-06558NEW1.92E-18COSMIC census399new9.40E-0342NEW2.80E-03In signature10,189old3.25E-361,608OLD3.70E-03STEM signature5,836old3.49E-63384OLD3.03E-07CD marker311new1.04E-1626NEW1.37E-06[^2][^3]

The data from GeneSigDB were difficult to interpret because genes in a signature can be up or down for the disease considered, but interestingly, genes in signatures were mostly old (possibly due to the bias of expression studies). This is especially true of genes with signatures for stem cells, whereas cell differentiation markers were instead overrepresented in new genes.

Many of these observations still applied when considering the age of the protein clusters in the MMM12+ network. We saw a higher representation of NEW clusters involving genes of differentiated cells, and mutated in cancer, and we also saw an overrepresentation of ciliopathy genes in the NEW clusters.

Although the ciliopathy genes are mostly old, many are clustering within the NEW network and are seen coevolving with newer animal-specific genes. *USH2A* and *GPR98* have been found to be mutated in Usher syndrome, a ciliopathy leading to deafness and blindness, and found to potentially interact in the extracellular gap ([@mss218-B27]). *PKHD1* is involved in polycystic and hepatic disease. We also saw several axonemal dynein proteins, involved in ciliary dyskinesia. In [figure 5](#mss218-F5){ref-type="fig"}, we show the MMM13+ network of only the ciliopathy genes and their first neighbors, indicating strong coevolution of genes particularly with *GPR98*, *USH2A*, *PKHD1*, *RP1,* and *MKKS.* F[ig]{.smallcaps}. 5.MMM13+ network of cilia/ciliopathy genes. Subnetwork of cilia/ciliopathy genes and their first neighbors in the MMM13+ network. Teal nodes indicate the cilia/ciliopathy genes. The thickness of the lines to their first neighbors is proportional to the MMM score.

### Cancer Genomes

#### Mutation Data.

With the advent of cancer genome sequencing, we sought to determine whether genes mutated in cancer could also be found in our MMM12+ network, as the data from COSMIC indicated, and as tight control of multicellular homeostasis should warrant.

We considered the data from the recent sequencing of ovarian serous cystadenocarcinoma (OSC) tumors ([@mss218-B50]) because mutation of the *BRCA2* gene is a risk factor for this cancer ([@mss218-B8]), which we found to be coevolving with cilia proteins in the NEW network. The *TP53* gene is the most frequently mutated gene in this cancer, representing about half of all mutations, so the observed number of other mutated genes is small. Nevertheless, we saw an overrepresentation of genes in the MMM12+ network as mutated in a relatively high number of patients ([fig. 6](#mss218-F6){ref-type="fig"} and [table 2](#mss218-T2){ref-type="table"}), particularly *USH2A*, *GPR98*, *PKHD1,* and several dynein proteins. F[ig]{.smallcaps}. 6.Frequency of mutated genes in ovarian serous cystadenocarcinoma tumors. The count of mutated genes (*y* axis) found in at least the number of tumor donor samples on the *x* axis is shown. Genes were annotated as being involved in cilia or ciliopathies (blue diamonds) or grouped by their evolutionary age (red circles for old and green triangles for new) and are black outlined when statistically significant (*P* \< 0.05). (*A*) The results are for all genes. (*B*) We only considered genes in the MMM12+ network. The MMM12+OLD genes were never overrepresented in the samples, but the cilia genes were highly overrepresented in the samples, as were the MMM12+NEW genes. Table 2.Mutations in Ovarian Serous Cystadenocarcinoma from the TCGA.Gene SymbolDonorsMMM12+Gene AgeCiliaGene SymbolDonorsMMM12+Gene AgeCilia[TP53258NEW]{.ul}PKHD19NEWNEW+TTN65NEWSI9NEWNEW[CSMD319NEW]{.ul}DNAH118NEWNEW+[FAT319NEW]{.ul}GPR988NEWNEW+USH2A19NEWNEW+ANK28NEWNEWMUC1618NEWAPC8NEWNEWRYR216NEWCOL22A18NEWNEWDST15NEWCOL6A38NEWNEWHMCN115NEWNEWPKHD1L18NEWNEWDNAH514NEWNEW+PPP1R3A8NEWNEWLRP1B14NEWTG8NEWNEWLRP214NEWNEWCRB17NEW+AHNAK12GLI27NEW+APOB12NEWNEWRP1L17NEW+DNAH312NEWNEW+FREM27NEWNEW[NF112NEW]{.ul}IGSF107NEWNEWAHNAK211NEWLAMA27NEWNEWFAT111NEWNEWLAMA37NEWNEWHYDIN11+MAP27NEWNEWMUC1711OLDPRKDC7NEWNEWODZ111NEWPTPRZ17NEWNEW[BRCA110NEWNEW]{.ul}STAB27NEWNEW[BRCA210NEWNEW]{.ul}SYNE27NEWNEWLRRK210NEWNEWVPS13B7NEWNEWMACF110NEWXIRP27NEWNEWRYR110NEWYSK47NEWNEWSYNE110NEWNEWZFYVE267NEWNEW[^4]

[Figure 6](#mss218-F6){ref-type="fig"}*A* plots the relationship between the total number of genes mutated against the cumulative number of donors with that number of mutations. Most of the relevant genes to cancer will thus appear in the most number of tumors. New genes appear most likely to be mutated (but they are also more frequent, so their overrepresentation in the set of cancer genes is not significant). In [figure 6](#mss218-F6){ref-type="fig"}*B*, we see that cilia genes and MMM12+NEW genes are highly mutated in this cancer, and this is statistically significant (outlined markers indicate statistically significant *P* values \< 0.05 for the number of mutations found in the cancer samples).

#### Expression Data.

The analysis of the Cancer Genome Atlas (TCGA) ovarian cancer data from both Agilent and Affymetrix arrays similarly showed a significant underexpression of cilia genes in ovarian cancer samples (supplementary results and [supplementary fig. S4](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). Because these data contained few normal samples to compare to the tumor samples, to confirm, we analyzed a smaller sample of microdissected tumors of high-grade serous carcinoma from fallopian tube samples, against their nonmalignant counterparts ([@mss218-B53]). We considered the average difference in the log of expression values between the tumor samples and the normal samples and found significant underexpression of the new versus old genes over all the probes for the 17,271 genes mapped to OMA (*P* = 2.1E − 29) or in MMM12+(*P* = 3.6E − 18). Cilia/ciliopathy genes were strikingly underexpressed in these tumor samples (*P =*6.6E − 105 in OMA and *P* = 2.8E − 31 in MMM12+). In [figure 7](#mss218-F7){ref-type="fig"}, we show the average expression values for the probes to cilia/ciliopathy genes and to the rest of the genes in OMA. Although the expression of noncilia genes did not vary considerably between tumors and normal samples, cilia genes had lower expression in tumor samples and higher expression in normal samples. F[ig]{.smallcaps}. 7.Expression of cilia-related genes in high-grade serous ovarian carcinomas. The average log expression values for the cilia/ciliopathy genes and those not annotated as such ([supplementary data set S2](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online) are shown for cancer samples (first 13 samples on the left), normal fallopian epithelial (FTE) cells from BRCA1-mutated donors (middle 12 samples), and normal fallopian epithelial cells from non-BRCA1 donors (rightmost 12 samples; see [@mss218-B53] for details). Asterisks indicate statistical significance of a two-tailed *t*-test at \**P* \< 0.05 or \*\**P* \< 0.01, for significant over- or underexpression of cilia/ciliopathy genes.

There were a few exceptional examples of annotated cilia genes that we found overexpressed in the ovarian tumors (several kinesins and aurora kinase A \[*AURKA*\]; [supplementary fig. S4](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). However, such overexpression could indicate the misannotation of these as cilia genes or possibly be attributed to alternative functions such as mitotic activity, as these genes are also important for mitosis. Interestingly, *AURKA* promotes the destabilization of the axoneme and cilium ([@mss218-B36]) and interacts with prometastatic protein *NEDD9* (a member of the MMM12+NEW network). In ovarian cancers, *AURKA* is overexpressed and *NEDD9* is amplified genetically ([@mss218-B50]) agreeing with the downregulation of cilia being associated with this disease.

Discussion
==========

In this work, we have analyzed the coevolution network of human proteins found with MMM and considered the coevolution of interactions deposited in many PPI databases. To do this, we required an accurate set of orthologous identifications to the human proteins. Deducing orthology is difficult due to the prevalence of gene and domain duplications. To address potential problems with orthologous identification and the misdating of proteins in the network, we applied two strategies for the clustering of orthologous sequences, and although there were differences in detail, our conclusions remained the same: the MMM coevolution network separates into two loosely linked subnetworks ([fig. 1](#mss218-F1){ref-type="fig"}*A*). Evolutionary dating of the two subnetworks, given the limitations of species distribution in our data set and the resolution of the phylogenetic tree, points to the separation around the emergence of multicellularity in animals. We thus investigated the functional differences between the proteins in these two subnetworks within this context.

MMM analysis revealed a network of coevolving genes that are more evolutionarily recent and not generally known to interact nor to be coexpressed. However, many of these MMM12+NEW network genes were absent from expression array surveys and are otherwise poorly characterized compared with genes that are conserved throughout the eukaryotes ([fig. 4](#mss218-F4){ref-type="fig"}). Moreover, the MMM12+NEW network could be showing coevolution between genes that are potentially coexpressed and interacting only at specific stages of development and in specific tissues, as is likely to be the case for more newly evolved genes specialized for differentiated, multicellular animals.

The OLD network, similar to what we had found for highly conserved proteins ([@mss218-B51]) and for proteins with yeast orthologs ([@mss218-B4]), showed higher levels of overall protein expression and thus appears to reflect ancient and fundamental interactions important for basic cellular function. In support of this, we found an overrepresentation of cell differentiation markers in the MMM12+NEW network, whereas the OLD network showed more genes involving markers of stem cells ([table 1](#mss218-T1){ref-type="table"}).

Our previous study ([@mss218-B4]) showed that MMM predictions of coevolution most agreed with the (gold standard) interactions in the yeast interaction network coming from mass spectrometry studies. The recent study of protein complexes in *Drosophila* ([@mss218-B13]) confirms this finding; however, that network is also extremely biased toward interactions between old proteins. The human network described here, especially when considering the NEW interactions, is thus more difficult to validate owing to the paucity of solid experimental data.

Many of the proteins in the MMM12+NEW network are extracellular, cytoskeletal, or nonsoluble membrane proteins, whose interactions are poorly characterized ([supplementary data set S3](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online), so it is unclear whether coevolution predicts actual physical protein--protein contacts in this network. The predicted interaction between *GPR98* and *USH2A* in mice was putatively confirmed as a physical interaction in [@mss218-B27], indicating that the known PPI databases are, unsurprisingly, incomplete. Despite the accumulation of literature-curated protein interaction data for model organisms such as yeast, allowing for the higher overlap of 20--30% for high-throughput PPI detection methods ([@mss218-B37]), high-quality human PPI maps are still incomplete ([@mss218-B6]; [@mss218-B17]). In addition, even though there has been significant progress in detecting PPI in multicellular organisms such as fly ([@mss218-B13]), these data would not necessarily apply well to the human proteins, because 60% of the human protein complexes are thought to have originated in vertebrates ([@mss218-B17]). The significant under-representation of old--new pairs found in the MMM12+ network is also found in the known PPI databases, such that on average, old proteins interact with old proteins and new with new ([supplementary table S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online).

An in silico approach has the strong advantage of not suffering from the same technical limitations and biases of laboratory experimentation, though our coevolutionary approach is itself limited in that it can only detect coevolution for proteins within a limited range of evolutionary rates ([fig. 3](#mss218-F3){ref-type="fig"}). Sequence coevolution can only be detected in genes that evolve sufficiently quickly to provide a signal but not so quickly as to saturate that signal. We found the correlated evolutionary rates in the NEW network to be increased relative to the OLD network. The fact that these proteins have just the right evolutionary rates to be detected by coevolution may not be coincidental, because an adaptation to multicellularity should coordinately increase the rate of evolution of those proteins involved.

We found a network of coevolving genes involved in cell--cell communication, the cytoskeleton, and the cell cycle, appearing crucial to the evolution and maintenance of multicellularity. Defects in their control would be expected to perturb multicellular homeostasis, and we indeed found a significant overrepresentation in this network of genes involved in ciliopathies and in cancer. This MMM12+NEW network still contains several old proteins, many related to the cilium. The cilium is an ancient appendage, dating to the origin of the eukaryotic cell ([@mss218-B16]), but it is still incompletely defined. (Because many of the experimental protocols investigating human protein interactions opt to employ dividing cell lines that are transformed---which in itself is an abnormal phenotype---and lack cilia, it is not surprising that the interactions involving ciliary proteins may be systemically overlooked.) To assemble a working set of cilia/ciliopathy genes, we mostly used annotations from GO and OMIM to find genes involved in human ciliopathies, supplemented with genes commonly found in the ciliome and ciliaproteome databases. These two databases of high-throughput gene expression ([@mss218-B18]) and proteomics and transcriptomics ([@mss218-B28]) data have little overlap with one another nor with human disease information and to some extent extrapolate from studies on ciliated or flagellated protists. Efforts to confirm these results in ciliated mammalian cell cultures have only just begun ([@mss218-B23]).

With the caveat that our set of human ciliome genes is probably incomplete, our coevolution network shows connections of several of these ancient proteins with the more recently arisen animal proteins. We also observed links to the centriole, implicating the centrosome and the control of cell division. Interestingly, this could indicate an adaptation of the originally motile cilia to so-called primary cilia, requiring new wiring to adapt the organelle to multicellularity. We did not observe coevolution with genes also involved in cytokinesis that localize at the basal body complex in vertebrate ciliated epithelial cells ([@mss218-B47]). Primary cilia play crucial roles in animals, particularly in vertebrate development ([@mss218-B11]), and loss of their function results in human genetic diseases, both ciliopathies ([@mss218-B9]; [@mss218-B52]) and cancer.

Some cancers are thought to be linked to ciliopathies due to the importance of cilia and centrosomes in the control of the cell cycle ([@mss218-B54]; [@mss218-B35]) and in aberrant activation or suppression of the Hedgehog (*Hh*) and *Wnt* pathways ([@mss218-B32]; [@mss218-B15]; [@mss218-B55]), *PDGFα* ([@mss218-B43]), and other signaling pathways ([@mss218-B29]). Loss of cilia has been observed in clear cell renal cell carcinoma ([@mss218-B44]), medulloblastoma ([@mss218-B15]), pancreatic cancer ([@mss218-B45]), astrocytoma/glioblastoma ([@mss218-B30]), and breast cancer ([@mss218-B56]).

Considering the data from the TCGA, we found the strongest evidence for mutated cilia genes in ovarian cancer and most particularly involving the subset of cilia-linked genes found to be coevolving in the MMM12+NEW network. Additional evidence from expression studies of these tumors also shows high-grade OSC tumors to have lower relative expression levels for many of the cilia genes compared with normal cells (supplementary results, [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) online). Investigation of tumors from microdissected fallopian epithelium samples confirmed these results. These cilia genes are at the center of the NEW network, which also includes *BRCA1* and *BRCA2*. *BRCA2* itself has been shown to localize to the centrosome and to nuclei; the dysfunction of *BRCA2* in the centrosome causes abnormalities in cell division ([@mss218-B31]). The dynein proteins *DNAH3* and *DNAH5* also seem particularly important in ovarian cancer and in our network. There is recent evidence that dynein-binding proteins may regulate the G1-S transition through an effect on cilia ([@mss218-B19]; [@mss218-B22]; [@mss218-B25]), such that ciliated cells require the loss of their cilia to enter the cell cycle.

Mutations in genes in the OLD network would most likely have the most severe phenotypes (depending on heterozygosity and penetrance). The OLD network did show an overrepresentation of disease genes, linked to an overrepresentation of enzyme deficiencies in metabolism ([table 1](#mss218-T1){ref-type="table"}). The NEW network, on the other hand, was found to be enriched for proteins involved in cancer and ciliopathies, thus proteins involved in cell communication, control of cell division, and cell differentiation, providing community homeostasis in a multicellular organism. The enrichment for such disease markers in the NEW network indicates a functional link between these coevolving proteins and provides genetic validation for this network.

With a better understanding of the relationships between ciliary function, important in cell control and communication, and cancer, reflecting the loss of such control and communication, the human coevolution network can help elucidate the processes most relevant to these classes of disease and more generally to the control and maintenance of a cooperative multicellular phenotype. Concerted evolutionary changes implicating the recruitment of the ancient cilium to these new roles should provide a fruitful impetus for further study.

Supplementary Material
======================

[Supplementary text S1, table S1](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1), [figures S1--S4, and data sets S1--S3](http://mbe.oxfordjournals.org/cgi/content/full/mss218/DC1) are available at *Molecular Biology and Evolution* online (<http://www.mbe.oxfordjournals.org/>).
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[^1]: **Associate editor:** Douglas Crawford

[^2]: ^a^new/old comparisons considered all genes mapped to OMA.

[^3]: ^b^NEW/OLD comparisons considered only the clusters in MMM12+.

[^4]: N[ote.]{.smallcaps}---The genes most frequently mutated are listed (removing silent, in frame, untranslated regions, flanking, noncoding, nonstop, intron, and splice sites/region mutations). In between seven and nine donors (on the right), only genes involved in cilia/ciliopathies and/or in the MMM12+ network are listed. Underlined genes were highlighted in TCGA's article ([@mss218-B50]).
